Skip to content

Improving access to Leishmaniasis treatment for women of childbearing age

Exploring gender-inclusive approaches to improve access to Leishmaniasis treatment for women of reproductive age in southern Bahia, Brazil

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-4mccfgk
Enrollment
198
Registered
2026-03-11
Start date
2025-09-22
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception

Interventions

Observational study based on interviews using two approaches: quantitative data analysis followed by discourse analysis. A total of 154 women will be approached for the initial questionnaire. In the q

Sponsors

Centro de Ciências da Saúde - Universidade Federal do Recôncavo da Bahia
Lead Sponsor
Centro de Ciências da Saúde - Universidade Federal do Recôncavo da Bahia
Collaborator

Eligibility

Age
15 Years to 49 Years

Inclusion criteria

Inclusion criteria: For interview using a quantitative approach (multiple-choice questionnaire) and qualitative approach (in-depth interview): people who identify as women; aged between 15 and 49 years; residing in endemic areas covered by selected primary health care units in Southern Bahia, Brazil; regardless of contraceptive use and/or pregnancy status, definitive sterilization or biological sex. For focus group discussions: community health workers; men and women; residing or working in the region and willing to contribute to the topic

Exclusion criteria

Exclusion criteria: Individuals who in the opinion of their treating physician (or the investigator if clinically qualified) are not clinically fit to participate

Design outcomes

Primary

MeasureTime frame
It is expected to confirm that the acceptability of modern contraceptive use among women of reproductive age (WRA) in Bahia, Brazil, as measured by standardized acceptability indicators, differs by more than 5% between two distinct situations: when contraceptives are indicated for medical reasons during standard leishmaniasis treatment and when they are used in the context of family planning

Secondary

MeasureTime frame
Secondary outcomes are not expected

Countries

BR

Contacts

Public ContactGláucia Cota

DnDi América Latina

gcota@dndi.org+55(21)2529-0400

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Apr 4, 2026